The intestinal epithelium acts as a frontline barrier against microbial invasion, frequently responding to infected or damaged cells by expelling them in a process known as extrusion. This protective mechanism limits pathogen spread and preserves tissue integrity. Central to the extrusion process are the Rho-associated coiled-coil containing kinases ROCK1 and ROCK2, which mediate cytoskeletal rearrangements crucial for the ejection of dying or compromised cells.

Using human Caco-2 cell lines infected with enterohaemorrhagic Escherichia coli (EHEC) O157:H7 and a derivative strain lacking the NleL gene, the investigators demonstrated an NleL-dependent decrease in caspase-4 and ROCK2 protein levels during infection. Importantly, treatment with the proteasome inhibitor bortezomib rescued the abundance of these proteins, indicating that NleL directs their proteasomal degradation. This finding situates NleL as a potent bacterial ubiquitin ligase capable of dismantling host defenses at a post-translational level.

Further exploration into the biochemical consequences of NleL activity revealed altered signaling downstream of ROCK. Specifically, infection with the NleL-deficient strain resulted in heightened phosphorylation of myosin light chain 2 (MLC2), a direct ROCK substrate, suggesting that NleL counteracts infection-induced ROCK-MLC2 activation. This disruption of signaling cascades likely impairs the host cell’s ability to execute cytoskeletal remodeling and extrusion.

To test the functional significance of ROCK1 and ROCK2 in epithelial extrusion, primary mouse IEC monolayers were exposed to FlaTox, which activates the NAIP-NLRC4 inflammasome prompting pyroptotic cell death. The application of Y-27632, a selective ROCK1/2 inhibitor, significantly impeded extrusion of propidium iodide-positive (dying) cells. Similarly, genetic ablation of Rock1 and Rock2 markedly reduced the extrusion response. These results establish that ROCK kinases are indispensable mediators of epithelial cell extrusion elicited by inflammasome activation.

The researchers then investigated whether bacterial modulation of ROCK impacts extrusion during infection. Monolayers infected with Citrobacter rodentium lacking NleL exhibited significantly increased cell extrusion compared to those infected with wild-type bacteria, indicating that NleL restricts this host defense. Complementation of the mutant strain with NleL normalized extrusion levels, reinforcing the causal role of this effector. Microscopic analyses confirmed close association between adherent bacteria and extruding cells, strengthening the link between NleL activity, ROCK modulation, and extrusion inhibition.

Translating these findings in vivo, the study employed tamoxifen-inducible Rock1 and Rock2 knockout mice with IEC-specific deletion to dissect the contribution of ROCK kinases in host defense against bacterial infection. Notably, deficiencies of Rock1 and Rock2 did not compromise intestinal barrier integrity, as assessed by fluorescein isothiocyanate (FITC)-dextran permeability assays. However, Rock-deficient mice exhibited increased levels of colonizing C. rodentium compared to controls, highlighting that ROCK1/2 promote containment and clearance of bacterial pathogens.

Further infection assays comparing colonization by wild-type and ΔnleL C. rodentium reinforced the importance of NleL-mediated ROCK degradation in promoting bacterial persistence. While the NleL mutant strain displayed impaired colonization and dissemination in control mice, this defect was rescued in animals lacking ROCK1/2, underscoring the functional interplay between bacterial effectors and host kinases in infectious dynamics.

Biochemical analyses of colonic IECs from infected mice revealed diminished ROCK1/2 expression following wild-type but not ΔnleL bacterial infection, providing in vivo evidence for NleL’s role in degrading these kinases. Complementing this, live-cell imaging of IEC monolayers demonstrated accelerated extrusion rates in cells infected with NleL-deficient bacteria, confirming the phenotypic impact of NleL on the host cell extrusion process.

Interestingly, although NleL also targets caspase-4, a pyroptotic mediator, infected IECs did not exhibit increased cell death or interleukin-18 secretion in response to ΔnleL bacteria. This indicates that NleL’s role in modulating ROCK-dependent extrusion is somewhat independent of its effects on pyroptosis, likely due to redundancy in bacterial strategies such as expression of the caspase inhibitor NleF.

This research elucidates a novel bacterial immune evasion strategy wherein enteropathogenic bacteria utilize the effector NleL to subvert ROCK1/2-driven epithelial extrusion, thereby sustaining infection and enhancing colonization. By coupling biochemical degradation of host cytoskeletal regulators to functional suppression of cell extrusion, these pathogens gain a critical foothold in the intestinal niche.

The study’s insights into the intersection of bacterial virulence and host cytoskeletal signaling hold promise for targeted therapeutic interventions. Disrupting NleL activity or restoring ROCK kinase function might enhance epithelial barrier defenses, presenting innovative avenues to combat enteric infections. Moreover, this work emphasizes the multifaceted strategies employed by pathogens to manipulate host innate immunity beyond conventional antimicrobial resistance.

As the intestinal epithelium serves as a critical battleground between host and microbes, understanding the molecular crosstalk governing cell fate and extrusion has profound implications for infectious disease, inflammation, and gut homeostasis. This study elevates the significance of ROCK kinases as central hubs exploited by pathogens to undermine epithelial integrity.

Future research building on these findings may explore the broader repertoire of bacterial effectors targeting cytoskeletal pathways, their impact on host-pathogen interactions, and potential exploitation in treatment strategies. The delicate interplay between ubiquitin ligases like NleL and host signaling nodes offers a remarkable glimpse into microbial subversion of host biology.

In sum, the discovery of NleL’s targeting of ROCK1 and ROCK2 to inhibit epithelial cell extrusion constitutes a major advance in our understanding of bacterial pathogenesis. This mechanistic insight spotlights the evolutionary arms race at the intestinal barrier and refines our grasp of the molecular underpinnings that dictate infection outcomes.

Subject of Research: Host-pathogen interactions, specifically how enteropathogenic bacteria modulate epithelial cell extrusion in the intestine.

Article Title: Enteropathogenic bacteria evade ROCK-driven epithelial cell extrusion.

Article References:
Luchetti, G., Miner, M.V., Peterson, R.M. et al. Enteropathogenic bacteria evade ROCK-driven epithelial cell extrusion. Nature (2025). https://doi.org/10.1038/s41586-025-09645-0

Image Credits: AI Generated

Ordinarily, the gastrointestinal tract is lined with a tightly sealed layer of epithelial cells forming a dynamic barrier that not only facilitates nutrient absorption but also acts as a vigilant sentinel against invading microbes. A critical innate defense involves the extrusion of infected epithelial cells — a process by which compromised cells are physically pushed out of the epithelial layer to be swiftly expelled from the body, effectively halting the progression of infection. This cell extrusion is regulated by specific molecular pathways, ensuring that infected or damaged cells do not persist and propagate infection.

The research team, comprising molecular microbiologists and biochemical experts from Genentech and Oregon Health & Science University (OHSU), has demonstrated that this harmful E. coli strain expresses a virulence protein named NleL, which subverts the extrusion process. NleL acts by targeting and dismantling Rho-associated protein kinases, specifically ROCK1 and ROCK2, enzymes pivotal for controlling the cytoskeletal dynamics that drive infected cell expulsion. The proteolytic activity of NleL thus cripples the cellular machinery that facilitates infected cell egress, enabling the bacteria to persist within the gut epithelium.

This discovery reveals a novel bacterial strategy that diverges markedly from established paradigms of immune evasion. While many pathogens evade host defenses by masking themselves to avoid immune detection, this E. coli strain directly sabotages the host cell’s ability to escape, effectively turning the epithelial defense mechanism on its head. By immobilizing infected cells, the bacteria gain an extended window to replicate intracellularly, subsequently increasing bacterial load and exacerbating infection severity.

The implications of this finding extend far beyond infectious disease, offering deep insights into gut biology and the delicate interplay between host tissues and microbiota. The gut epithelium has historically been perceived as a passive barrier, but research continues to underscore its active role in immune surveillance and rapid response to microbial insult. The elucidation of ROCK-dependent epithelial extrusion pathways and their subversion by pathogens marks a significant advancement in our understanding of gut mucosal immunity.

The lead investigator, Isabella Rauch, Ph.D., an associate professor at OHSU specializing in molecular microbiology and immunology, emphasized the transformative nature of this mechanism. “Our findings uncover a completely novel bacterial approach: rather than hiding, this pathogen directly obstructs a critical host defense pathway,” she noted. “This has wide-reaching implications for how we think about host-pathogen interactions.”

Central to their research methodology was the integration of sophisticated biochemical assays and cutting-edge gut tissue models. Genentech scientists characterized the molecular activity of NleL, revealing its enzymatic breakdown of ROCK1/2, while Rauch’s lab employed in vitro systems mimicking human intestinal tissue to observe the functional consequences of NleL expression on epithelial cell behavior. This multidisciplinary collaboration allowed for compelling evidence that these molecular interactions translate into tangible effects on gut epithelial integrity during infection.

Beyond expanding basic scientific knowledge, the study opens promising avenues for therapeutic intervention. Conventional treatments for bacterial infections largely rely on antibiotics, which indiscriminately target bacterial viability and are increasingly compromised by rising antimicrobial resistance. Targeting virulence factors such as NleL could present an alternative therapeutic strategy that disarms pathogens without killing them directly, thereby reducing selective pressures for resistance development.

Furthermore, this mechanism may provide new understanding related to chronic gut disorders. Diseases such as inflammatory bowel disease (IBD) are characterized by dysregulated epithelial turnover and excessive extrusion, contributing to barrier dysfunction and persistent inflammation. Investigating how extrusion pathways are modulated or disrupted can shed light on the pathogenesis of IBD and potentially gastrointestinal malignancies wherein epithelial homeostasis is disrupted.

The public health ramifications of these findings are profound, particularly as climate change and lapses in food safety regulations threaten to escalate the incidence of such bacterial infections globally. Vulnerable populations, especially young children in low-resource settings, face heightened risk due to their limited capacity to withstand fluid loss caused by infection. Efforts to monitor and control foodborne pathogens must therefore intensify in conjunction with deeper molecular insights into pathogen-host interactions gained from studies like this.

In conclusion, this seminal work not only reveals an unprecedented bacterial evasion tactic but also reinforces the intricate functionality of the gut epithelium as an active immunological participant. By delineating how pathogenic E. coli hinders epithelial cell extrusion through enzymatic disruption of ROCK kinases, the research paves the way for innovative anti-virulence therapies. Such approaches promise to complement or even supersede traditional antibiotics, marking an exciting frontier in combating enteric infections and improving gastrointestinal health.

Subject of Research: Bacterial pathogenesis and host epithelial defense mechanisms in the gut.

Article Title: Enteropathogenic bacteria evade ROCK-driven epithelial cell extrusion

News Publication Date: Not specified in the provided content

Web References:

• Nature article: https://www.nature.com/articles/s41586-025-09645-0
• DOI link: http://dx.doi.org/10.1038/s41586-025-09645-0

References:

• Publication in Nature
• Research collaboration between Genentech (Roche Group) and Oregon Health & Science University

Keywords: Bacteria, Gut microbiota, Enteropathogenic E. coli, Epithelial cell extrusion, ROCK1/ROCK2 kinases, Gut epithelium, Anti-virulence therapy, Inflammatory bowel disease (IBD), Microbial pathogenesis, Host-pathogen interaction